Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Fixed Price - SME
₹ 13.05
₹ 72
1600
₹ 1,15,200.00
NSE - SME
16-Jan-2023
19-Jan-2023
30-Jan-2023
Initial public issue of 18,12,800 equity shares of Rs. 10/- each (Equity Shares) of Aristo Bio-Tech and Lifescience Limited (ABLL or the Company or the Issuer) for cash at a price of Rs. 72/- per equity share including a share premium of Rs. 62/- per equity share (the Issue Price), aggregating to Rs. 13.05 crores (The Issue), of which 91,200 equity shares of Rs. 10/- each for cash at a price of Rs. 72/- per equity share including a share premium of Rs. 62/- per equity share aggregating to Rs. 0.66 crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less market maker reservation portion i.e. issue of 17,21,600 equity shares of Rs. 10/- each including a share premium of Rs. 62/- per equity share aggregating to Rs. 12.40 crores is hereinafter referred to as the Net Issue. The issue and the net issue will constitute 26.63% and 25.29%, respectively of the post issue paid up equity share capital of the company.The face value of the equity share is Rs. 10/- and the issue price is Rs. 72/- the issue price is 7.2 times of the face value.Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter.
To meet working capital requirement. General corporate expenses.
Aristo Bio-Tech & Lifescience Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083
Phone - 91-22-49186000
Fax - 91-22-49186060
Email - cs@aristobiotech.com
Website - www.aristobiotech.com